Denise Neves Gameiro, Author at Labiotech.eu

About

Journalist intern. Studied Bioengineering in Porto and was a lab rat in Sweden. Enjoying Berlin and the company of Labiotech’s resident plants.

Articles by Denise Neves Gameiro

wheat meiogenix spix epigenetics cambridge bbrsc

News and Trends 28 Apr 2016

French Biotech and Cambridge to improve Food Security with UK Grant

Meiogenix and the University of Cambridge will get fresh money to investigate how epigenomics impacts crop diversity – and how it can be engineered for better yields of wheat. Based in Paris, Meiogenix is developing breeding technologies – which already caught the eye of Bayer Crop Science. One of its platforms is SpiX, which increases the […]

April 28, 2016 - 2 minutesmins - By Denise Neves Gameiro

morphosys novartis muscle simb bimagrumab

News and Trends 27 Apr 2016

‘Disappointing results’ for Novartis & MorphoSys phase III in Muscle Disease

MorphoSys confirms that its antibody (bimagrumab) failed to meet the primary endpoint of a phase IIb/III trial for a muscle disease (sIBM), conducted by Novartis. Sad news for Novartis and MorphoSys. The two companies are developing bimagrumab for muscle diseases, as part of their ongoing collaboration, which has already resulted in 11 programmes. Bimagrumab was initially […]

April 27, 2016 - 2 minutesmins - By Denise Neves Gameiro

pharnext pleodrug charcot marie tooth cmt1a

News and Trends 27 Apr 2016

French Pleodrug for Rare Neurological Disease opens up phase III trial in US

Pharnext is opening their first US study sites for a phase III trial in a rare neuropathy – a milestone in the development of Pharnext’s leading candidate. Based in Paris (France), Pharnext is developing new therapies for neurological conditions, including rare diseases such as Charcot-Marie-Tooth Disease. Pharnext uses network pharmacology to discover synergistic combinations of drugs […]

April 27, 2016 - 2 minutesmins - By Denise Neves Gameiro

txcell ospedale san raffaele lupus nephritis car treg

News and Trends 27 Apr 2016

CAR-T for Lupus with French-Italian Partnership

TxCell and Ospedale San Raffaele have partnered up to research a new treatment for Lupus, based on engineered regulatory T-cells (CAR-Treg). TxCell is developing immunotherapies based on the discovery of a type of T-cells that have anti-inflammatory properties – regulatory T lymphocytes (Tregs). Tregs have already yielded two candidates. Osave is currently on phase IIb […]

April 27, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 26 Apr 2016

Illumina is Suing over NGS Prenatal Screening… Again

Genoma is being sued by Illumina over four patents covering technology for prenatal testing, that uses NGS to diagnose fetal defects. After suing Oxford Nanopore over porin technology, Illumina is back to another contentious field – their patents for a type of non-invasive prenatal testing (NIPT). Illumina has filed a patent infringement suit in the Federal […]

April 26, 2016 - 2 minutesmins - By Denise Neves Gameiro

bioviva ageing gene therapy telomerase parrish

News and Trends 25 Apr 2016

Anti-ageing DIY Gene Therapy may have worked – to an extent…

The weird tale of BioViva‘s CEO receiving non-approved gene therapy to fight ageing has developed further – now with ‘successful results’, which have been verified by two EU research NGOs. There may be something to it after all? Stopping ageing has always been a dream of mankind – and one that is slowly beginning to […]

April 25, 2016 - 3 minutesmins - By Denise Neves Gameiro

astrazeneca centre genomics research hli wellcome fimm

News and Trends 25 Apr 2016

AstraZeneca partners up with Genomics Elite for new Biobank

AstraZeneca has announced it will create a new Centre for Genomics Research in Cambridge (UK) – joining the Wellcome Sanger, a Craig Venter Biotech and a Finnish specialist Institute to do so. AstraZeneca is betting on genomics to transform drug discovery and support its R&D pipeline. The idea is to create a ‘biobank‘ with genome analysis, integrated with data from […]

April 25, 2016 - 3 minutesmins - By Denise Neves Gameiro

kiweno bianca gfrei lecture food intolerance diagnostic

News and Trends 25 Apr 2016

The DIY Allergy Blood Test inspiring Austria’s startup Scene

I got to hear the interesting story and business model of kiweno, a digital health startup and rising star in Austria. What’s the product, where is the demand and were there challenges with perceptions after the Theranos scandal? Berlin has a lot of exciting events to feed the thriving startup scene here. And really at […]

April 25, 2016 - 6 minutesmins - By Denise Neves Gameiro

TC biopharm immunicell melanoma kidney cancer

News and Trends 25 Apr 2016

Scottish Biopharma begins Cell Therapy trials for Late-Stage Cancer

TC BioPharm has began recruitment to a phase II/III trial with its lead candidate (ImmuniCell), a T-cell therapy now targeting skin, lung and kidney cancer. Based in Scotland, TC BioPharm is developing cell-based therapies for cancer and severe viral infection. These therapies are based on γδ T-cells, which can recognise and target specific structures on the cell surface […]

April 25, 2016 - 2 minutesmins - By Denise Neves Gameiro

saphetor ngs lausanne university hospital endocrine

News and Trends 22 Apr 2016

Swiss Biotech to Investigate rare Endocrine Disorders with NGS

Saphetor is developing genome-scale analysis of next generation sequencing (NGS) results – and will now ‘play’ with real data of Endocrine patients at the Lausanne University Hospital. Based in Lausanne’s EPFL Innovation Park (Switzerland), Saphetor was founded only in 2014 and completed a seed financing round this February, raising around €1M (1.2M CHF). This startup develops proprietary […]

April 22, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 21 Apr 2016

New CRISPR Tool can cut RNA too: Gene Editing just got even Easier!

The research team led by Emannuelle Charpentier, co-discoverer of the CRISPR/Cas9 system, has found that a new CRISPR system can also cleave RNA. Amazingly simple! The discovery of the CRISPR/Cas9 system revolutionised Biotechnology, unlocking a kind of ‘Golden age’ for gene editing – with a wide-reaching impact from therapeutics to SynBio. So, it’s no wonder that […]

April 21, 2016 - 3 minutesmins - By Denise Neves Gameiro

aacr 2016 merus transgene debiopharma innate

News and Trends 21 Apr 2016

These EU Biotechs presented groundbreaking results at World Biggest Cancer Meeting

The annual meeting of the American Association for Cancer Research (AACR) has just finished. From Europe, who made a splash with their results? The AACR annual meeting is the world’s biggest conference in Cancer research, and the must-attend event for Biotechs developing cancer therapies. The 2016 edition took place in New Orleans (US) from the […]

April 21, 2016 - 5 minutesmins - By Denise Neves Gameiro

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Denise Neves Gameiro

About

Articles by Denise Neves Gameiro

French Biotech and Cambridge to improve Food Security with UK Grant

‘Disappointing results’ for Novartis & MorphoSys phase III in Muscle Disease

French Pleodrug for Rare Neurological Disease opens up phase III trial in US

CAR-T for Lupus with French-Italian Partnership

Illumina is Suing over NGS Prenatal Screening… Again

Anti-ageing DIY Gene Therapy may have worked – to an extent…

AstraZeneca partners up with Genomics Elite for new Biobank

The DIY Allergy Blood Test inspiring Austria’s startup Scene

Scottish Biopharma begins Cell Therapy trials for Late-Stage Cancer

Swiss Biotech to Investigate rare Endocrine Disorders with NGS

New CRISPR Tool can cut RNA too: Gene Editing just got even Easier!

These EU Biotechs presented groundbreaking results at World Biggest Cancer Meeting

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

About

Articles by Denise Neves Gameiro

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!